Literature DB >> 3495815

Lymphoma: evaluation with Ga-67 SPECT.

S S Tumeh, D S Rosenthal, W D Kaplan, R J English, B L Holman.   

Abstract

To determine the value of gallium-67 single photon emission computed tomography (SPECT) in imaging patients with lymphoma, the authors compared Ga-67 planar images and SPECT images in 40 consecutive patients, using radiologic examinations and/or medical records to confirm the presence or absence of disease. Thirty-three patients had Hodgkin disease, and seven had non-Hodgkin lymphoma. Fifty-four examinations were performed. Of 57 sites of lymphoma in the chest, planar imaging depicted 38, while SPECT depicted 55, resulting in sensitivities of 0.66 and 0.96 for planar and SPECT imaging, respectively. In eight sites, both modalities were truly negative, but SPECT was negative in four additional sites that were equivocal on planar imaging, resulting in specificities of 0.66 and 1.00 for planar and SPECT imaging, respectively. In the abdomen, the sensitivities of planar and SPECT imaging were 0.69 and 0.85, and the specificities 0.87 and 1.00, respectively. SPECT was more accurate in depicting foci of gallium-avid lymphoma in the chest and abdomen and in excluding disease when planar imaging was equivocal.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495815     DOI: 10.1148/radiology.164.1.3495815

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.

Authors:  I Ionescu; P Brice; D Simon; A Guermazi; T Leblanc; P Rousselot; D Gossot; V Meignin; C Gisselbrecht; J D Rain
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 2.  The role of nuclear medicine in clinical investigation.

Authors:  E M Prvulovich; J B Bomanji
Journal:  BMJ       Date:  1998-04-11

3.  Usefulness of Ga-67 brain SPECT in patients with CNS malignant lymphoma.

Authors:  H Fujii; S Kosuda; K Suzuki; H Yorino; S Akita; H Negishi; O Nakamura; N Shitara; A Kubo
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

4.  Does leukocyte scintigraphy answer the need for a more widely available radiopharmaceutical that can detect and assess the proliferative state of lymphoma?

Authors:  C Van de Wiele; M Simons; L Noens; R A Dierckx
Journal:  Eur J Nucl Med       Date:  1996-04

Review 5.  Current role of gallium scanning in the management of lymphoma.

Authors:  A F McLaughlin; M A Magee; R Greenough; K C Allman; A E Southee; S R Meikle; B F Hutton; D E Joshua; G J Bautovich; J G Morris
Journal:  Eur J Nucl Med       Date:  1990

6.  Recurrent mediastinal mass in a child with Hodgkin's disease following successful therapy: a diagnostic challenge.

Authors:  A Feldges; H P Wagner; B Bubeck; B Kehrer; G Ries; U Schmid; P Waibel
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

Review 7.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

8.  The role of gallium-67 tumour scintigraphy in patients with small, non-cleaved cell lymphoma.

Authors:  D Sandrock; S Lastoria; I T Magrath; R D Neumann
Journal:  Eur J Nucl Med       Date:  1993-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.